Addington, A. M.; Gornick, M.; Duckworth, J.; Sporn, A.; Gogtay, N.; Bobb, A.; Greenstein, D.; Lenane, M.; Gochman, P.; Baker, N.; Balkissoon, R.;
Vakkalanka, R. K.; Weinberger, D. R.; Rapoport, J. L.; Straub, R. E. (2004):
GAD1 (2q31.1), which encodes glutamic acid decarboxylase (GAD67), is associated with childhood-onset schizophrenia and cortical gray matter volume loss. In: Molecular psychiatry 10 (6), S. 581–588.
Alexopoulos, P.; Richter-Schmidinger, T.; Horn, M.; Maus, S.; Reichel, M.;
Sidiropoulos, C.; Rhein, C.; Lewczuk, P.; Doerfler, A.; Kornhuber, J. (2011):
Hippocampal volume differences between healthy young apolipoprotein E ε2 and ε4 carriers. In: Journal of Alzheimer's disease : JAD 26 (2), S. 207–210.
Andersen, S. L. (2003): Trajectories of brain development: point of
vulnerability or window of opportunity? In: Neuroscience and biobehavioral reviews 27 (1-2), S. 3–18.
Arinami, T.; Yamada, N.; Yamakawa-Kobayashi, K.; Hamaguchi, H.; Toru, M.
(1997): Methylenetetrahydrofolate reductase variant and
schizophrenia/depression. In: American journal of medical genetics 74 (5), S.
526–528.
Blom, H. J.; Smulders, Y. (2011): Overview of homocysteine and folate metabolism. With special references to cardiovascular disease and neural tube defects. In: Journal of inherited metabolic disease 34 (1), S. 75–81.
Boccardi, M.; Scassellati, C.; Ghidoni, R.; Testa, C.; Benussi, L.; Bonetti, M.;
Bocchio-Chiavetto, L.; Gennarelli, M.; Binetti, G.; Frisoni, G. B. (2008): Effect of the XbaI polymorphism of estrogen receptor alpha on postmenopausal gray matter. In: Neuroscience letters 434 (3), S. 304–309.
Bottiglieri, T.; Laundy, M.; Crellin, R.; Toone, B. K.; Carney, M. W.; Reynolds, E. H. (2000): Homocysteine, folate, methylation, and monoamine metabolism in depression. In: Journal of neurology, neurosurgery, and psychiatry 69 (2), S. 228–232.
Botto, L. D.; Yang, Q. (2000): 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. In: American journal of epidemiology 151 (9), S. 862–877.
Brandon, N. J.; Millar, J. K.; Korth, C.; Sive, H.; Singh, K. K.; Sawa, A.
(2009): Understanding the role of DISC1 in psychiatric disease and during normal development. In: The Journal of neuroscience: the official journal of the society for neuroscience 29 (41), S. 12768–12775.
Brandon, N. J.; Sawa, A. (2011): Linking neurodevelopmental and synaptic theories of mental illness through DISC1. In: Nature reviews. Neuroscience 12 (12), S. 707–722.
Brauns, S.; Gollub, R. L.; Roffman, J. L.; Yendiki, A.; Ho, B.-C.; Wassink, T.
H.; Heinz, A.; Ehrlich, S. (2011): DISC1 is associated with cortical thickness and neural efficiency. In: NeuroImage 57 (4), S. 1591–1600.
Burdick, K. E.; Kamiya, A.; Hodgkinson, C. A.; Lencz, T.; DeRosse, P.;
Ishizuka, K.; Elashvili, S.; Arai, H.; Goldman, D.; Sawa, A.; Malhotra, A. K.
(2008): Elucidating the relationship between DISC1, NDEL1 and NDE1 and
61
the risk for schizophrenia: Evidence of epistasis and competitive binding. In:
Human molecular genetics 17 (16), S. 2462–2473.
Buss, R. R.; Sun, W.; Oppenheim, R. W. (2006): Adaptive roles of programmed cell death during nervous system development. In: Annual review of neuroscience 29, S. 1–35.
Callicott, J. H.; Straub, R. E.; Pezawas, L.; Egan, M. F.; Mattay, V. S.; Hariri, A. R.; Verchinski, B. A.; Meyer-Lindenberg, A.; Balkissoon, R.; Kolachana, B.; Goldberg, T. E.; Weinberger, D. R. (2005): Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia. In:
Proceedings of the National Academy of Sciences of the United States of America 102 (24), S. 8627–8632.
Camargo, L. M.; Collura, V.; Rain, J.-C.; Mizuguchi, K.; Hermjakob, H.;
Kerrien, S.; Bonnert, T. P.; Whiting, P. J.; Brandon, N. J. (2007): Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia. In: Molecular psychiatry 12 (1), S. 74–86.
Cannon, T. D.; Hennah, W.; van Erp, T. G.; Thompson, P. M.; Lonnqvist, J.;
Huttunen, M.; Gasperoni, T.; Tuulio-Henriksson, A.; Pirkola, T.; Toga, A. W.;
Kaprio, J.; Mazziotta, J.; Peltonen, L. (2005): Association of DISC1/TRAX haplotypes with schizophrenia, reduced prefrontal gray matter, and impaired short- and long-term memory. In: Archives of general psychiatry 62 (11), S.
1205–1213.
Cariaso, M.; Lennon, G. (2012): SNPedia: a wiki supporting personal
genome annotation, interpretation and analysis. In: Nucleic acids research 40 (D1), S. D1308.
Cascalheira, J. F.; João, S. S.; Pinhanços, S. S.; Castro, R.; Palmeira, M.;
Almeida, S.; Faria, M. C.; Domingues, F. C. (2009): Serum homocysteine:
interplay with other circulating and genetic factors in association to Alzheimer's type dementia. In: Clinical biochemistry 42 (9), S. 783–790.
Cerasa, A.; Gioia, M. C.; Labate, A.; Liguori, M.; Lanza, P.; Quattrone, A.
(2008): Impact of catechol-O-methyltransferase Val108/158 Met genotype on hippocampal and prefrontal gray matter volume. In: NeuroReport 19 (4), S.
405–408.
Chakravarty, M. M.; Felsky, D.; Tampakeras, M.; Lerch, J. P.; Mulsant, B. H.;
Kennedy, J. L.; Voineskos, A. N. (2012): DISC1 and striatal volume: a potential risk phenotype for mental illness. In: Frontiers in psychiatry 3.
Chubb, J. E.; Bradshaw, N. J.; Soares, D. C.; Porteous, D. J.; Millar, J. K.
(2008): The DISC locus in psychiatric illness. In: Molecular psychiatry 13 (1), S. 36–64.
Clarke, R.; Daly, L.; Robinson, K.; Naughten, E.; Cahalane, S.; Fowler, B.;
Graham, I. (1991): Hyperhomocysteinemia: an independent risk factor for
62
vascular disease. In: The New England journal of medicine 324 (17), S.
1149–1155.
Courchesne, E.; Chisum, H. J.; Townsend, J.; Cowles, A.; Covington, J.;
Egaas, B.; Harwood, M.; Hinds, S.; Press, G. A. (2000): Normal brain development and aging: quantitative analysis at in vivo MR imaging in healthy volunteers. In: Radiology 216 (3), S. 672–682.
del Río Garcia, C.; Torres-Sánchez, L.; Chen, J.; Schnaas, L.; Hernández, C.; Osorio, E.; Portillo, M. G.; López-Carrillo, L. (2009): Maternal MTHFR 677CT genotype and dietary intake of folate and vitamin B(12): their impact on child neurodevelopment. In: Nutritional neuroscience 12 (1), S. 13–20.
Di Giorgio, A.; Blasi, G.; Sambataro, F.; Rampino, A.; Papazacharias, A.;
Gambi, F.; Romano, R.; Caforio, G.; Rizzo, M.; Latorre, V.; Popolizio, T.;
Kolachana, B.; Callicott, J. H.; Nardini, M.; Weinberger, D. R.; Bertolino, A.
(2008): Association of the SerCys DISC1 polymorphism with human
hippocampal formation gray matter and function during memory encoding. In:
The European journal of neuroscience 28 (10), S. 2129–2136.
Dror, D. K.; Allen, L. H. (2008): Effect of vitamin B12 deficiency on
neurodevelopment in infants: current knowledge and possible mechanisms.
In: Nutrition reviews 66 (5), S. 250–255.
Eastwood, S. L.; Walker, M.; Hyde, T. M.; Kleinman, J. E.; Harrison, P. J.
(2010): The DISC1 Ser704Cys substitution affects centrosomal localization of its binding partner PCM1 in glia in human brain. In: Human molecular
genetics 19 (12), S. 2487–2496.
Ekelund, J.; Hennah, W.; Hiekkalinna, T.; Parker, A.; Meyer, J.; Lönnqvist, J.;
Peltonen, L. (2004): Replication of 1q42 linkage in Finnish schizophrenia pedigrees. In: Molecular psychiatry 9 (11), S. 1037–1041.
Ekelund, J.; Hovatta, I.; Parker, A.; Paunio, T.; Varilo, T.; Martin, R.;
Suhonen, J.; Ellonen, P.; Chan, G.; Sinsheimer, J. S.; Sobel, E.; Juvonen, H.;
Arajärvi, R.; Partonen, T.; Suvisaari, J.; Lönnqvist, J.; Meyer, J.; Peltonen, L.
(2001): Chromosome 1 loci in Finnish schizophrenia families. In: Human molecular genetics 10 (15), S. 1611–1617.
Fanapour, P. C.; Yug, B.; Kochar, M. S. (1999): Hyperhomocysteinemia: an additional cardiovascular risk factor. In: Wisconsin medical journal 98 (8), S.
51–54.
Fattal-Valevski, A.; Bassan, H.; Korman, S. H.; Lerman-Sagie, T.; Gutman, A.; Harel, S. (2000): Methylenetetrahydrofolate reductase deficiency:
importance of early diagnosis. In: Journal of child neurology 15 (8), S. 539–
543.
Franchis, R. de; Buoninconti, A.; Mandato, C.; Pepe, A.; Sperandeo, M. P.;
Del Gado, R.; Capra, V.; Salvaggio, E.; Andria, G.; Mastroiacovo, P. (1998):
The C677T mutation of the 5,10-methylenetetrahydrofolate reductase gene is a moderate risk factor for spina bifida in Italy. In: Journal of medical genetics 35 (12), S. 1009–1013.
Frosst, P.; Blom, H. J.; Milos, R.; Goyette, P.; Sheppard, C. A.; Matthews, R.
G.; Boers, G. J.; den Heijer, M.; Kluijtmans, L. A.; van den Heuvel, L. P.
63
(1995): A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. In: Nature genetics 10 (1), S. 111–113.
Gilbert, Scott F. (2010): Developmental Biology. 9. Aufl. Sunderland, Mass:
Sinauer Associates.
Goyette, P.; Frosst, P.; Rosenblatt, D. S.; Rozen, R. (1995): Seven novel mutations in the methylenetetrahydrofolate reductase gene and
genotype/phenotype correlations in severe methylenetetrahydrofolate reductase deficiency. In: American journal of human genetics 56 (5), S.
1052–1059.
Greenblatt, J. M.; Huffman, L. C.; Reiss, A. L. (1994): Folic acid in neurodevelopment and child psychiatry. In: Progress in neuro-psychopharmacology & biological psychiatry 18 (4), S. 647–660.
Hashimoto, R.; Numakawa, T.; Ohnishi, T.; Kumamaru, E.; Yagasaki, Y.;
Ishimoto, T.; Mori, T.; Nemoto, K.; Adachi, N.; Izumi, A.; Chiba, S.; Noguchi, H.; Suzuki, T.; Iwata, N.; Ozaki, N.; Taguchi, T.; Kamiya, A.; Kosuga, A.;
Tatsumi, M.; Kamijima, K.; Weinberger, D. R.; Sawa, A.; Kunugi, H. (2006):
Impact of the DISC1 Ser704Cys polymorphism on risk for major depression, brain morphology and ERK signaling. In: Human molecular genetics 15 (20), S. 3024–3033.
Hennah, W.; Porteous, D. (2009): The DISC1 pathway modulates expression of neurodevelopmental, synaptogenic and sensory perception genes. In:
PloS one 4 (3), S. e4906.
Hennah, W.; Tuulio-Henriksson, A.; Paunio, T.; Ekelund, J.; Varilo, T.;
Partonen, T.; Cannon, T. D.; Lönnqvist, J.; Peltonen, L. (2005): A haplotype within the DISC1 gene is associated with visual memory functions in families with a high density of schizophrenia. In: Molecular psychiatry 10 (12), S.
1097–1103.
Hennah, W.; Varilo, T.; Kestilä, M.; Paunio, T.; Arajärvi, R.; Haukka, J.;
Parker, A.; Martin, R.; Levitzky, S.; Partonen, T.; Meyer, J.; Lönnqvist, J.;
Peltonen, L.; Ekelund, J. (2003): Haplotype transmission analysis provides evidence of association for DISC1 to schizophrenia and suggests sex-dependent effects. In: Human molecular genetics 12 (23), S. 3151–3159.
Hirschhorn, J. N.; Lohmueller, K.; Byrne, E.; Hirschhorn, K. (2002): A comprehensive review of genetic association studies. In: Genetics in medicine 4 (2), S. 45–61.
Ho, B.-C.; Milev, P.; O’Leary, D. S.; Librant, A.; Andreasen, N. C.; Wassink, T. H. (2006): Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers. In: Archives of general psychiatry 63 (7), S. 731.
Hodgkinson, C. A.; Goldman, D.; Jaeger, J.; Persaud, S.; Kane, J. M.; Lipsky, R. H.; Malhotra, A. K. (2004): Disrupted in schizophrenia 1 (DISC1):
association with schizophrenia, schizoaffective disorder, and bipolar disorder.
In: American journal of human genetics 75 (5), S. 862–872.
64
Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis (2002). In: Journal of the American medical association 288 (16), S. 2015–
2022.
Hua, Y.; Zhao, H.; Kong, Y.; Ye, M. (2011): Association between the MTHFR gene and Alzheimer's disease: a meta-analysis. In: International journal of neuroscience 121 (8), S. 462–471.
Jacques, P. F.; Bostom, A. G.; Williams, R. R.; Ellison, R. C.; Eckfeldt, J. H.;
Rosenberg, I. H.; Selhub, J.; Rozen, R. (1996): Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. In: Circulation 93 (1), S. 7–9.
James, R.; Adams, R. R.; Christie, S.; Buchanan, S. R.; Porteous, D. J.;
Millar, J. K. (2004): Disrupted in Schizophrenia 1 (DISC1) is a
multicompartmentalized protein that predominantly localizes to mitochondria.
In: Molecular and cellular neurosciences 26 (1), S. 112–122.
Johnson, M. B.; Kawasawa, Y. I.; Mason, C. E.; Krsnik, Ž.; Coppola, G.;
Bogdanović, D.; Geschwind, D. H.; Mane, S. M.; State, M. W.; Šestan, N.
(2009): Functional and evolutionary insights into human brain development through global transcriptome analysis. In: Neuron 62 (4), S. 494–509.
Jönsson, E. G.; Larsson, K.; Vares, M.; Hansen, T.; Wang, A. G.; Djurovic, S.; Rønningen, K. S.; Andreassen, O. A.; Agartz, I.; Werge, T.; Terenius, L.;
Hall, H. (2008): Two methylenetetrahydrofolate reductase gene (MTHFR) polymorphisms, schizophrenia and bipolar disorder: an association study. In:
American journal of medical genetics. Part B, Neuropsychiatric genetics 147 (6), S. 976–982.
Kamiya, A.; Kubo, K.-i.; Tomoda, T.; Takaki, M.; Youn, R.; Ozeki, Y.;
Sawamura, N.; Park, U.; Kudo, C.; Okawa, M.; Ross, C. A.; Hatten, M. E.;
Nakajima, K.; Sawa, A. (2005): A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development. In: Nature cell biology 7 (12), S. 1167–1178.
Kamiya, A.; Sedlak, T. W.; Pletnikov, M. V. (2012): DISC1 Pathway in Brain Development: Exploring Therapeutic Targets for Major Psychiatric Disorders.
In: Frontiers in psychiatry 3, S. 25.
Kempisty, B.; Bober, A.; Łuczak, M.; Czerski, P.; Szczepankiewicz, A.;
Hauser, J.; Jagodziński, P. P. (2007): Distribution of 1298AC polymorphism of methylenetetrahydrofolate reductase gene in patients with bipolar disorder and schizophrenia. In: European psychiatry 22 (1), S. 39–43.
Kempisty, B.; Mostowska, A.; Górska, I.; Łuczak, M.; Czerski, P.;
Szczepankiewicz, A.; Hauser, J.; Jagodziński, P. P. (2006): Association of 677CT polymorphism of methylenetetrahydrofolate reductase (MTHFR) gene with bipolar disorder and schizophrenia. In: Neuroscience letters 400 (3), S.
267–271.
Kilpinen, H.; Ylisaukko-Oja, T.; Hennah, W.; Palo, O. M.; Varilo, T.; Vanhala, R.; Nieminen-von Wendt, T.; Wendt, L. von; Paunio, T.; Peltonen, L. (2008):
Association of DISC1 with autism and Asperger syndrome. In: Molecular psychiatry 13 (2), S. 187–196.
65
Knickmeyer, R. C.; Wang, J.; Zhu, H.; Geng, X.; Woolson, S.; Hamer, R. M.;
Konneker, T.; Lin, W.; Styner, M.; Gilmore, J. H. (2014): Common variants in psychiatric risk genes predict brain structure at birth. In: Cerebral Cortex 24 (5), S. 1230–1246.
Korth, C. (2009): DISCopathies: brain disorders related to DISC1 dysfunction. In: Reviews in the neurosciences 20 (5-6), S. 321–330.
Kunugi, H.; Fukuda, R.; Hattori, M.; Kato, T.; Tatsumi, M.; Sakai, T.; Hirose, T.; Nanko, S. (1998): C677T polymorphism in methylenetetrahydrofolate reductase gene and psychoses. In: Molecular psychiatry 3 (5), S. 435–437.
La Rosa, E. J. de; Pablo, F. de (2000): Cell death in early neural
development: beyond the neurotrophic theory. In: Trends in neurosciences 23 (10), S. 454–458.
Lemaître, H.; Crivello, F.; Dufouil, C.; Grassiot, B.; Tzourio, C.; Alpérovitch, A.; Mazoyer, B. (2005): No ɛ4 gene dose effect on hippocampal atrophy in a large MRI database of healthy elderly subjects. In: NeuroImage 24 (4), S.
1205–1213.
Liem, F.; Mérillat, S.; Bezzola, L.; Hirsiger, S.; Philipp, M.; Madhyastha, T.;
Jäncke, L. (2015): Reliability and statistical power analysis of cortical and subcortical FreeSurfer metrics in a large sample of healthy elderly. In:
NeuroImage 108, S. 95–109.
Lipska, B. K.; Peters, T.; Hyde, T. M.; Halim, N.; Horowitz, C.; Mitkus, S.;
Weickert, C. S.; Matsumoto, M.; Sawa, A.; Straub, R. E.; Vakkalanka, R.;
Herman, M. M.; Weinberger, D. R.; Kleinman, J. E. (2006): Expression of DISC1 binding partners is reduced in schizophrenia and associated with DISC1 SNPs. In: Human molecular genetics 15 (8), S. 1245–1258.
Mackie, S.; Millar, J. K.; Porteous, D. J. (2007): Role of DISC1 in neural development and schizophrenia. In: Current opinion in neurobiology 17 (1), S. 95–102.
Mansoori, N.; Tripathi, M.; Luthra, K.; Alam, R.; Lakshmy, R.; Sharma, S.;
Arulselvi, S.; Parveen, S.; Mukhopadhyay, A. K. (2012): MTHFR (677 and 1298) and IL-6-174 G/C genes in pathogenesis of Alzheimer's and vascular dementia and their epistatic interaction. In: Neurobiology of aging 33 (5), S.
1003.e1-8.
Mansouri, L.; Fekih-Mrissa, N.; Klai, S.; Mansour, M.; Gritli, N.; Mrissa, R.
(2013): Association of methylenetetrahydrofolate reductase polymorphisms with susceptibility to Alzheimer's disease. In: Clinical neurology and
neurosurgery 115 (9), S. 1693–1696.
Mao, Y.; Ge, X.; Frank, C. L.; Madison, J. M.; Koehler, A. N.; Doud, M. K.;
Tassa, C.; Berry, E. M.; Soda, T.; Singh, K. K.; Biechele, T.; Petryshen, T. L.;
Moon, R. T.; Haggarty, S. J.; Tsai, L.-H. (2009): Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3beta/beta-catenin signaling. In: Cell 136 (6), S. 1017–1031.
Marini, N. J.; Gin, J.; Ziegle, J.; Keho, K. H.; Ginzinger, D.; Gilbert, D. A.;
Rine, J. (2008): The prevalence of folate-remedial MTHFR enzyme variants
66
in humans. In: Proceedings of the national academy of sciences of the United States of America 105 (23), S. 8055–8060.
Mata, I.; Perez-Iglesias, R.; Roiz-Santiañez, R.; Tordesillas-Gutierrez, D.;
Gonzalez-Mandly, A.; Berja, A.; Vazquez-Barquero, J. L.; Crespo-Facorro, B.
(2010): Additive effect of NRG1 and DISC1 genes on lateral ventricle
enlargement in first episode schizophrenia. In: NeuroImage 53 (3), S. 1016–
1022.
McCully, K. S. (1969): Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. In: The American journal of
pathology 56 (1), S. 111–128.
McTigue, D. M.; Tripathi, R. B. (2008): The life, death, and replacement of oligodendrocytes in the adult CNS. In: Journal of neurochemistry 107 (1), S.
1–19.
Millar, J. K.; Christie, S.; Anderson, S.; Lawson, D.; Hsiao-Wei Loh, D.;
Devon, R. S.; Arveiler, B.; Muir, W. J.; Blackwood, D. H.; Porteous, D. J.
(2001): Genomic structure and localisation within a linkage hotspot of
Disrupted in schizophrenia 1, a gene disrupted by a translocation segregating with schizophrenia. In: Molecular psychiatry 6 (2), S. 173–178.
Millar, J. K.; Wilson-Annan, J. C.; Anderson, S.; Christie, S.; Taylor, M. S.;
Semple, C. A.; Devon, R. S.; St Clair, D. M.; Muir, W. J.; Blackwood, D. H.;
Porteous, D. J. (2000): Disruption of two novel genes by a translocation co-segregating with schizophrenia. In: Human molecular genetics 9 (9), S.
1415–1423.
Montag, C.; Weber, B.; Fliessbach, K.; Elger, C.; Reuter, M. (2009): The BDNF Val66Met polymorphism impacts parahippocampal and amygdala volume in healthy humans: incremental support for a genetic risk factor for depression. In: Psychological medicine 39 (11), S. 1831.
Morris, J. A.; Kandpal, G.; Ma, L.; Austin, C. P. (2003): DISC1 (Disrupted-In-Schizophrenia 1) is a centrosome-associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: regulation and loss of interaction with mutation. In: Human molecular genetics 12 (13), S. 1591–1608.
Nakata, K.; Lipska, B. K.; Hyde, T. M.; Ye, T.; Newburn, E. N.; Morita, Y.;
Vakkalanka, R.; Barenboim, M.; Sei, Y.; Weinberger, D. R.; Kleinman, J. E.
(2009): DISC1 splice variants are upregulated in schizophrenia and
associated with risk polymorphisms. In: Proceedings of the national academy of sciences of the United States of America 106 (37), S. 15873–15878.
Norambuena, P. A.; Copeland, J. A.; Krenková, P.; Stambergová, A.; Macek, M. (2009): Diagnostic method validation: High resolution melting (HRM) of small amplicons genotyping for the most common variants in the MTHFR gene. In: Clinical biochemistry 42 (12), S. 1308–1316.
Ohnishi, T.; Hashimoto, R.; Mori, T.; Nemoto, K.; Moriguchi, Y.; Iida, H.;
Noguchi, H.; Nakabayashi, T.; Hori, H.; Ohmori, M.; Tsukue, R.; Anami, K.;
Hirabayashi, N.; Harada, S.; Arima, K.; Saitoh, O.; Kunugi, H. (2006): The association between the Val158Met polymorphism of the catechol-O-methyl transferase gene and morphological abnormalities of the brain in chronic schizophrenia. In: Brain 129 (2), S. 399–410.
67
Ozbek, Z.; Kucukali, C. I.; Ozkok, E.; Orhan, N.; Aydin, M.; Kilic, G.; Sazci, A.; Kara, I. (2008): Effect of the methylenetetrahydrofolate reductase gene polymorphisms on homocysteine, folate and vitamin B12 in patients with bipolar disorder and relatives. In: Progress in neuro-psychopharmacology &
biological psychiatry 32 (5), S. 1331–1337.
Palo, O. M.; Antila, M.; Silander, K.; Hennah, W.; Kilpinen, H.; Soronen, P.;
Tuulio-Henriksson, A.; Kieseppä, T.; Partonen, T.; Lönnqvist, J.; Peltonen, L.;
Paunio, T. (2007): Association of distinct allelic haplotypes of DISC1 with psychotic and bipolar spectrum disorders and with underlying cognitive impairments. In: Human molecular genetics 16 (20), S. 2517–2528.
Peerbooms, O. L.; van Os, J.; Drukker, M.; Kenis, G.; Hoogveld, L.; Hert, M.
de; Delespaul, P.; van Winkel, R.; Rutten, B. P. (2011): Meta-analysis of MTHFR gene variants in schizophrenia, bipolar disorder and unipolar
depressive disorder: evidence for a common genetic vulnerability? In: Brain, behavior, and immunity 25 (8), S. 1530–1543.
Pezawas, L. (2004): The brain derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. In: Journal of neuroscience 24 (45), S. 10099–10102.
Plassman, B. L.; Welsh-Bohmer, K. A.; Bigler, E. D.; Johnson, S. C.;
Anderson, C. V.; Helms, M. J.; Saunders, A. M.; Breitner, J. C. (1997):
Apolipoprotein E epsilon 4 allele and hippocampal volume in twins with normal cognition. In: Neurology 48 (4), S. 985–989.
Rabinowicz, T.; Courten-Myers, G. M. de; Petetot, J. M.; Xi, G.; los Reyes, E.
de (1996): Human cortex development: estimates of neuronal numbers indicate major loss late during gestation. In: Journal of neuropathology and experimental neurology 55 (3), S. 320–328.
Rajagopalan, P.; Jahanshad, N.; Stein, J. L.; Hua, X.; Madsen, S. K.;
Kohannim, O.; Hibar, D. P.; Toga, A. W.; Jack, C. R.; Saykin, A. J.; Green, R.
C.; Weiner, M. W.; Bis, J. C.; Kuller, L. H.; Riverol, M.; Becker, J. T.; Lopez, O. L.; Thompson, P. M. (2012): Common folate gene variant, MTHFR C677T, is associated with brain structure in two independent cohorts of people with mild cognitive impairment. In: NeuroImage: Clinical 1 (1), S. 179–187.
Raznahan, A.; Lee, Y.; Long, R.; Greenstein, D.; Clasen, L.; Addington, A.;
Rapoport, J. L.; Giedd, J. N. (2010): Common functional polymorphisms of DISC1 and cortical maturation in typically developing children and
adolescents. In: Molecular psychiatry 16 (9), S. 917–926.
Reichel, M.; Richter-Schmidinger, T.; Mühle, C.; Rhein, C.; Alexopoulos, P.;
Schwab, S. G.; Gulbins, E.; Kornhuber, J. (2014): The common acid sphingomyelinase polymorphism p.G508R is associated with self-reported allergy. In: Cellular physiology and biochemistry 34 (1), S. 82–91.
Reif, A.; Pfuhlmann, B.; Lesch, K.-P. (2005): Homocysteinemia as well as methylenetetrahydrofolate reductase polymorphism are associated with affective psychoses. In: Progress in neuro-psychopharmacology & biological psychiatry 29 (7), S. 1162–1168.
68
Reiss, A. L.; Abrams, M. T.; Singer, H. S.; Ross, J. L.; Denckla, M. B. (1996):
Brain development, gender and IQ in children. A volumetric imaging study.
In: Brain 119 (Pt 5), S. 1763–1774.
Rhein, C.; Mühle, C.; Richter-Schmidinger, T.; Alexopoulos, P.; Doerfler, A.;
Kornhuber, J. (2014): Neuroanatomical correlates of intelligence in healthy young adults: the role of basal ganglia volume. In: PloS one 9 (4), S. e93623.
Richter-Schmidinger, T.; Alexopoulos, P.; Horn, M.; Maus, S.; Reichel, M.;
Rhein, C.; Lewczuk, P.; Sidiropoulos, C.; Kneib, T.; Perneczky, R.; Doerfler, A.; Kornhuber, J. (2011): Influence of brain-derived neurotrophic-factor and apolipoprotein E genetic variants on hippocampal volume and memory performance in healthy young adults. In: Journal of neural transmission 118 (2), S. 249–257.
Rohen, Johannes W.; Lütjen-Drecoll, Elke (2012): Funktionelle Embryologie.
Die Entwicklung Der Funktionssysteme Des Menschlichen Organismus; 4.
Aufl. Stuttgart: Schattauer.
Sazci, A.; Ergül, E.; Güzelhan, Y.; Kaya, G.; Kara, I. (2003):
Methylenetetrahydrofolate reductase gene polymorphisms in patients with schizophrenia. In: Brain research. Molecular brain research 117 (1), S. 104–
107.
Sazci, A.; Ergul, E.; Kucukali, I.; Kara, I.; Kaya, G. (2005): Association of the C677T and A1298C polymorphisms of methylenetetrahydrofolate reductase gene with schizophrenia: association is significant in men but not in women.
In: Progress in neuro-psychopharmacology & biological psychiatry 29 (7), S.
1113–1123.
Scharinger, C.; Rabl, U.; Sitte, H. H.; Pezawas, L. (2010): Imaging genetics of mood disorders. In: NeuroImage 53 (3), S. 810–821.
Shaw, P.; Lerch, J. P.; Pruessner, J. C.; Taylor, K. N.; Rose, A. B.;
Greenstein, D.; Clasen, L.; Evans, A.; Rapoport, J. L.; Giedd, J. N. (2007):
Cortical morphology in children and adolescents with different apolipoprotein E gene polymorphisms: an observational study. In: The Lancet neurology 6 (6), S. 494–500.
Shields, D. C.; Kirke, P. N.; Mills, J. L.; Ramsbottom, D.; Molloy, A. M.;
Burke, H.; Weir, D. G.; Scott, J. M.; Whitehead, A. S. (1999): The
"thermolabile" variant of methylenetetrahydrofolate reductase and neural tube defects: An evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother. In: American journal of human genetics 64 (4), S. 1045–1055.
Sidiropoulos, C.; Jafari-Khouzani, K.; Soltanian-Zadeh, H.; Mitsias, P.;
Alexopoulos, P.; Richter-Schmidinger, T.; Reichel, M.; Lewczuk, P.; Doerfler, A.; Kornhuber, J. (2011): Influence of brain-derived neurotrophic factor and apolipoprotein E genetic variants on hemispheric and lateral ventricular volume of young healthy adults. In: Acta neuropsychiatrica 23 (3), S. 132–
138.
Singh, K. K.; Rienzo, G. de; Drane, L.; Mao, Y.; Flood, Z.; Madison, J.;
Ferreira, M.; Bergen, S.; King, C.; Sklar, P.; Sive, H.; Tsai, L.-H. (2011):
69
Common DISC1 polymorphisms disrupt Wnt/GSK3β signaling and brain development. In: Neuron 72 (4), S. 545–558.
Soares, D. C.; Carlyle, B. C.; Bradshaw, N. J.; Porteous, D. J. (2011): DISC1:
structure, function, and therapeutic potential for major mental illness. In: ACS chemical neuroscience 2 (11), S. 609–632.
St Clair, D.; Blackwood, D.; Muir, W.; Carothers, A.; Walker, M.; Spowart, G.;
Gosden, C.; Evans, H. J. (1990): Association within a family of a balanced autosomal translocation with major mental illness. In: Lancet 336 (8706), S.
13–16.
Stanisławska-Sachadyn, A.; Woodside, J. V.; Brown, K. S.; Young, I. S.;
Murray, L.; McNulty, H.; Strain, J.; Boreham, C. A.; Scott, J. M.; Whitehead, A. S. (2008): Evidence for sex differences in the determinants of
homocysteine concentrations. In: Molecular genetics and metabolism 93 (4), S. 355–362.
Stiles, J.; Jernigan, T. L. (2010): The basics of brain development. In:
Neuropsychology review 20 (4), S. 327–348.
Stuart, S.; Cox, H. C.; Lea, R. A.; Griffiths, L. R. (2012): The role of the MTHFR gene in migraine. In: Headache 52 (3), S. 515–520.
Szeszko, P. R.; Hodgkinson, C. A.; Robinson, D. G.; DeRosse, P.; Bilder, R.
M.; Lencz, T.; Burdick, K. E.; Napolitano, B.; Betensky, J. D.; Kane, J. M.;
Goldman, D.; Malhotra, A. K. (2008): DISC1 is associated with prefrontal cortical gray matter and positive symptoms in schizophrenia. In: Biological pPsychology 79 (1), S. 103–110.
Takahashi, T.; Suzuki, M.; Tsunoda, M.; Maeno, N.; Kawasaki, Y.; Zhou, S.-Y.; Hagino, H.; Niu, L.; Tsuneki, H.; Kobayashi, S.; Sasaoka, T.; Seto, H.;
Kurachi, M.; Ozaki, N. (2009): The Disrupted-in-Schizophrenia-1 Ser704Cys polymorphism and brain morphology in schizophrenia. In: Psychiatry
research 172 (2), S. 128–135.
Tan, E.-C.; Chong, S.-A.; Lim, L. C.; Chan, A. O.; Teo, Y.-Y.; Tan, C.-H.;
Mahendran, R. (2004): Genetic analysis of the thermolabile
methylenetetrahydrofolate reductase variant in schizophrenia and mood disorders. In: Psychiatric genetics 14 (4), S. 227–231.
Tau, G. Z.; Peterson, B. S. (2009): Normal development of brain circuits. In:
Neuropsychopharmacology 35 (1), S. 147–168.
Taylor, M. S.; Devon, R. S.; Millar, J. K.; Porteous, D. J. (2003): Evolutionary constraints on the Disrupted in Schizophrenia locus. In: Genomics 81 (1), S.
67–77.
Taylor, W. D.; Züchner, S.; Payne, M. E.; Messer, D. F.; Doty, T. J.; MacFall, J. R.; Beyer, J. L.; Krishnan, K. R. (2007): The COMT Val158Met
polymorphism and temporal lobe morphometry in healthy adults. In:
Psychiatry research: Neuroimaging 155 (2), S. 173–177.
Thomson, P. A.; Wray, N. R.; Millar, J. K.; Evans, K. L.; Le Hellard, S.;
Condie, A.; Muir, W. J.; Blackwood, D. H.; Porteous, D. J. (2005): Association between the TRAX/DISC locus and both bipolar disorder and schizophrenia in the Scottish population. In: Molecular psychiatry 10 (7), S. 657-68, 616.
70
Tran, P.; Leclerc, D.; Chan, M.; Pai, A.; Hiou-Tim, F.; Wu, Q.; Goyette, P.;
Artigas, C.; Milos, R.; Rozen, R. (2002): Multiple transcription start sites and alternative splicing in the methylenetetrahydrofolate reductase gene result in two enzyme isoforms. In: Mammalian genome13 (9), S. 483–492.
van der Put, N. M.; Gabreëls, F.; Stevens, E. M.; Smeitink, J. A.; Trijbels, F.
J.; Eskes, T. K.; van den Heuvel, L. P.; Blom, H. J. (1998): A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? In: American journal of human genetics 62 (5), S. 1044–1051.
van der Put, N. M.; Steegers-Theunissen, R. P.; Frosst, P.; Trijbels, F. J.;
Eskes, T. K.; van den Heuvel, L. P.; Mariman, E. C.; den Heyer, M.; Rozen, R.; Blom, H. J. (1995): Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. In: Lancet 346 (8982), S. 1070–1071.
van der Put, N. M.; van Straaten, H. W.; Trijbels, F. J.; Blom, H. J. (2001):
Folate, homocysteine and neural tube defects: an overview. In: Experimental biology and medicine 226 (4), S. 243–270.
Wang, F.; Jiang, T.; Sun, Z.; Teng, S.-L.; Luo, X.; Zhu, Z.; Zang, Y.; Zhang, H.; Yue, W.; Qu, M.; Lu, T.; Hong, N.; Huang, H.; Blumberg, H. P.; Zhang, D.
(2009): Neuregulin 1 genetic variation and anterior cingulum integrity in patients with schizophrenia and healthy controls. In: Journal of psychiatry &
neuroscience: JPN 34 (3), S. 181–186.
Watkins, D.; Rosenblatt, D. S. (2012): Update and new concepts in vitamin responsive disorders of folate transport and metabolism. In: Journal of inherited metabolic disease 35 (4), S. 665–670.
Whitehead, V. M. (2006): Acquired and inherited disorders of cobalamin and folate in children. In: British journal of haematology 134 (2), S. 125–136.
Whitehead, A. S.; Gallagher, P.; Mills, J. L.; Kirke, P. N.; Burke, H.; Molloy, A.
M.; Weir, D. G.; Shields, D. C.; Scott, J. M. (1995): A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects. In: QJM: monthly journal of the association of physicians 88 (11), S. 763–766.
Winterer, G.; Konrad, A.; Vucurevic, G.; Musso, F.; Stoeter, P.; Dahmen, N.
(2008): Association of 5′ end neuregulin-1 (NRG1) gene variation with subcortical medial frontal microstructure in humans. In: NeuroImage 40 (2), S. 712–718.
Yates, A.; Akanni, W.; Amode, M. R.; Barrell, D.; Billis, K.; Carvalho-Silva, D.;
Cummins, C.; Clapham, P.; Fitzgerald, S.; Gil, L.; Girón, C. G.; Gordon, L.;
Hourlier, T.; Hunt, S. E.; Janacek, S. H.; Johnson, N.; Juettemann, T.;
Keenan, S.; Lavidas, I.; Martin, F. J.; Maurel, T.; McLaren, W.; Murphy, D. N.;
Nag, R.; Nuhn, M.; Parker, A.; Patricio, M.; Pignatelli, M.; Rahtz, M.; Riat, H.
S.; Sheppard, D.; Taylor, K.; Thormann, A.; Vullo, A.; Wilder, S. P.; Zadissa, A.; Birney, E.; Harrow, J.; Muffato, M.; Perry, E.; Ruffier, M.; Spudich, G.;
Trevanion, S. J.; Cunningham, F.; Aken, B. L.; Zerbino, D. R.; Flicek, P.
(2016): Ensembl 2016. In: Nucleic acids research 44 (D1), S. D710.
(a) http://Aug2017.archive.ensembl.org/Homo_sapiens/Gene/Summary?db=
core;g=ENSG00000162946;r=1:231626815-232041272 [Stand 27.11.2017]
(b) http://Aug2017.archive.ensembl.org/Homo_sapiens/Gene/Summary?db=
71
core;g=ENSG00000177000;r=1:11785723-11806920 [Stand 27.11.2017]
Zeisel, S. H. (2009): Importance of methyl donors during reproduction. In:
Zeisel, S. H. (2009): Importance of methyl donors during reproduction. In: